Other Briefings
India’s Semiconductor Sector: Tracking Government Support and Investment Trends
India’s Tata Electronics and Dutch firm ASML have signed an MoU on May 16, 2026, to support the development of India’s first front-end semiconductor fabrication facility in Gujarat. As of May 18, 2026, India has a total of 13 approved semiconductor projects under ISM and SPECS.
Outside the ISM: How Rajasthan’s Bhiwadi Commissioned India’s 13th Semiconductor Unit
Sahasra Semiconductors has established India’s 13th packaging node at Rajasthan’s Bhiwadi semiconductor facility under the SPECS framework on May 15, 2026, integrating the state into the domestic electronic supply chain.
Deepfake, Personality Rights and Corporate Liability in India in 2026
Deepfake liability in India has evolved into a cross-functional governance challenge, necessitating a converged response across privacy, cybercrime, consumer protection, and intellectual property frameworks.
India’s Toys Story: Riding the US$186 Million Export Wave to 153 Countries
India’s toy exports stood at US$186.22 million in FY 2025-26, highlighting the country’s growing role in the global toy industry. We explore India’s evolving “toyconomy” in 2026 with market projections reaching US$4.74 billion by 2034.
Maharashtra Investment Guide 2026: Opportunities in India’s Industrial Powerhouse
Learn why Maharashtra remains India’s top investment destination in 2026. We analyze industrial corridors, seaport export data, stamp duty frameworks, and new labor law flexibilities for businesses.
India’s M&A Trends Q1 2026: Deals, Sectors, and Investment Outlook
India’s Q1 2026 M&A (mergers and acquisitions) market saw a 5 percent volume surge to 710 deals despite falling values. Learn why mid-market shifts and outbound expansion are the new growth drivers in the country.
BIS Certification in India (FMCS Scheme I): 2026 Guide for Foreign Manufacturers
Learn how foreign manufacturers can obtain BIS certification under FMCS Scheme I, manage QCO compliance, avoid import disruptions, and streamline market entry into India.
Why Indian Critical Drug Exports are Surging in 2026: The Role of FTAs
India’s critical drug manufacturing enters a new growth phase in 2026. From oncology dominance to zero-duty access under new FTAs, learn how India is transitioning into a high-value global hub for specialty drugs, vaccines, & anti-infective formulations.
